Are you connecting the dots?
RIVERSIDE, Calif. — Vaccinations can be a controversial subject for many people, especially when it comes to injections. So what if you could replace your next shot with a salad instead? Researchers at the University of California-Riverside are working on a way to grow edible plants that carry the same medication as an mRNA vaccine.
The COVID-19 vaccine is one of the many inoculations which use messenger RNA (mRNA) technology to defeat viruses. They work by teaching cells from the immune system to recognize and attack a certain infectious disease. Unfortunately, mRNA vaccines have to stay in cold storage until use or they lose stability. The UC-Riverside team says if they’re successful, the public could eat plant-based mRNA vaccines — which could also survive at room temperature.
Thanks to a $500,000 grant from the National Science Foundation, researchers are now looking accomplish three goals. First, the team will try to successfully deliver DNA containing mRNA vaccines into plant cells, where they can replicate. Next, the study authors want to show that plants can actually produce enough mRNA to replace a traditional injection. Finally, the team will need to determine the right dosage people will need to eat to properly replace vaccinations.
“Ideally, a single plant would produce enough mRNA to vaccinate a single person,” says Juan Pablo Giraldo, an associate professor in UCR’s Department of Botany and Plant Sciences, in a university release.
“We are testing this approach with spinach and lettuce and have long-term goals of people growing it in their own gardens,” Giraldo adds. “Farmers could also eventually grow entire fields of it.”
Plants are capable of growing more vaccines
Giraldo and a team of scientists from UC-San Diego and Carnegie Mellon University say the key to making edible vaccines are chloroplasts. These are small organs inside plant cells which help convert sunlight into energy.
“They’re tiny, solar-powered factories that produce sugar and other molecules which allow the plant to grow,” Giraldo explains. “They’re also an untapped source for making desirable molecules.”
Previous studies have shown that it’s possible for chloroplasts to express genes which are not a natural part of that plant. Giraldo’s team accomplished this by sending genetic material inside of a protective casing into plant cells.
In the new study, Giraldo teamed with UC-San Diego’s Professor Nicole Steinmetz to use nanotechnology to deliver more genetic material into chloroplasts.
“Our idea is to repurpose naturally occurring nanoparticles, namely plant viruses, for gene delivery to plants,” Steinmetz says. “Some engineering goes into this to make the nanoparticles go to the chloroplasts and also to render them non-infectious toward the plants.”
“One of the reasons I started working in nanotechnology was so I could apply it to plants and create new technology solutions. Not just for food, but for high-value products as well, like pharmaceuticals,” Giraldo adds. SOURCE
Just so the reader would see that this is not “science fiction” but reality, I found confirmation from NIH:
The prevalence of the coronavirus disease 2019 (COVID-19) pandemic in its second year has led to massive global human and economic losses. The high transmission rate and the emergence of diverse SARS-CoV-2 variants demand rapid and effective approaches to preventing the spread, diagnosing on time, and treating affected people. Several COVID-19 vaccines are being developed using different production systems, including plants, which promises the production of cheap, safe, stable, and effective vaccines. The potential of a plant-based system for rapid production at a commercial scale and for a quick response to an infectious disease outbreak has been demonstrated by the marketing of carrot-cell-produced taliglucerase alfa (Elelyso) for Gaucher disease and tobacco-produced monoclonal antibodies (ZMapp) for the 2014 Ebola outbreak. Currently, two plant-based COVID-19 vaccine candidates, coronavirus virus-like particle (CoVLP) and Kentucky Bioprocessing (KBP)-201, are in clinical trials, and many more are in the preclinical stage. Interim phase 2 clinical trial results have revealed the high safety and efficacy of the CoVLP vaccine, with 10 times more neutralizing antibody responses compared to those present in a convalescent patient’s plasma. The clinical trial of the CoVLP vaccine could be concluded by the end of 2021, and the vaccine could be available for public immunization thereafter. This review encapsulates the efforts made in plant-based COVID-19 vaccine development, the strategies and technologies implemented, and the progress accomplished in clinical trials and preclinical studies so far. (emphasis added)
Now think about this, brothers and sisters in Christ: FOOD cannot be Patented because it grows on the earth. But FOOD which has been manipulated to contain “Vaccines” is no longer natural food.
And you guessed it: Gates and the rest of the mad scientists will OWN our food. So while they are getting richer, we will either be starving or filled with killer vaccines.